Intangible Assets (Tables)

3 Months Ended

Sep. 30, 2012

Intangible Assets

Summary of Intangible assets, net

	Gross Carrying Amount				Accumulated Amortization						Intangible Assets, Net
(In thousands)	September 30, 2012		June 30, 2012		September 30, 2012			June 30, 2012			September 30, 2012		June 30, 2012
JSP Marketing and Dist. Rights	$	16,062	$	16,062	$	(13,385	)	$	(12,939	)	$	2,677	$	3,123
Cody Labs Import License	582		582		(163		)	(154		)	419		428
Morphine Sulfate Oral Solution NDA	398		398		(31		)	(24		)	367		374
Other ANDA Product Rights(A)	600		600		(105		)	(96		)	495		504
	$	17,642	$	17,642	$	(13,684	)	$	(13,213	)	$	3,958	$	4,429

(A)  The amounts above include the product line covered by the ANDA’s purchased in August 2009 for $149.  These ANDA’s are not being amortized at this time and will continue to be un-amortized intangible assets until such time as the Company begins shipping these products.

Summary of intangible assets, net activity

(In thousands)	Intangible assets, net
Balances at July 1, 2012	$	4,429
Additions	—
Amortization	(471		)
Impairments	—
Balances at September 30, 2012	$	3,958

Summary of future annual amortization expense

(In thousands) Fiscal Year Ending June 30,	Annual Amortization Expense
2013	$	1,411
2014	1,435
2015	97
2016	97
2017	97
Thereafter	672
	$	3,809